Crohn's disease Trials in Braga, Portugal
Conditions / Crohn's disease / Braga, Portugal
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |
| NCT03466411 | A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT06548542 | Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease | RECRUITING | PHASE2 |
| NCT03635112 | Efficacy and Safety of TD-1473 in Crohn's Disease | TERMINATED | PHASE2 |
| NCT02914561 | Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT05068284 | A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE2 |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | RECRUITING | — |
| NCT02914600 | Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease | TERMINATED | PHASE3 |
| NCT02130362 | A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) | ACTIVE_NOT_RECRUITING | — |
| NCT02641392 | A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease | TERMINATED | PHASE3 |